| Literature DB >> 24839441 |
Parviz Mohajeri1, Gita Darfarin2, Abbas Farahani3.
Abstract
Background and Objective. Urinary tract infection (UTI) is one of the most common bacterial infections in the world. Molecular fingerprinting of UTI isolates such as pulsed-Field Gel Electrophoresis using for Clonal distribution and determine of predominant type. The aim of the study was to determine genotyping of ESBL producing UPECs. Material and Methods. 200 UPEC isolates from outpatients with UTI were obtained. Antimicrobial susceptibility and interpretation were performed by disk diffusion. Virulence factors for UPECs were screened by using PCR. UPECs were analyzed by Pulsed-Field Gel Electrophoresis and images analyzed by Phoretix1DPro software. Results. A total of 200 isolates of UPECs, 24.5% (n = 49) of isolates, were positive for ESBL production. Resistance ranged from 0% for amikacin and imipenem to over 93.9% for carbenicillin and ampicillin. Frequencies of haemagglutination, haemolysin, and hydrophobicity were 51%, 18.3%, and 14.28%, respectively. A total of 10 different genotypes were obtained, which include nine common clones and one single clone. Conclusion. We confirmed the prevalence of virulence phenotyping especially Haemagglutination among UPEC strains and that it can also contribute to virulence in these strains. Large diversity in genotypes was observed in the isolates that could be indicative of different sources of infection in community acquired.Entities:
Year: 2014 PMID: 24839441 PMCID: PMC4009276 DOI: 10.1155/2014/276941
Source DB: PubMed Journal: Int J Microbiol
Figure 1Pulsed-field gel electrophoresis dendrogram of UPEC isolates. The vertical black line shows the 80% cut-off.
Figure 2CHEF profiles of UPEC strains isolated. Lateral lanes contain Lambda Ladder PFG Marker. Size range: 48.5 kb to 679 kb (14 fragments).
Antimicrobial-susceptibility for UPEC strains.
| Antibiotics | Susceptibility; number (%) of isolates: | |||||
|---|---|---|---|---|---|---|
| Susceptible | Intermediate | Resistant | ||||
| Number | % | Number | % | Number | % | |
| Amikacin | 46 | 93/9 | 3 | 6/1 | 0 | 0 |
| Ampicillin | 3 | 6/1 | 0 | 0 | 46 | 93/9 |
| Aztreonam | 11 | 22/4 | 2 | 4/1 | 36 | 73/5 |
| Carbenicillin | 3 | 6/1 | 0 | 0 | 46 | 93/9 |
| Cefoperazone | 9 | 18/4 | 4 | 8/2 | 36 | 73/5 |
| Ceftriaxone | 11 | 22/4 | 2 | 4/1 | 36 | 73/5 |
| Cefuroxim | 10 | 20/4 | 1 | 2 | 38 | 77/6 |
| Ciprofloxacin | 26 | 53/1 | 2 | 4/1 | 21 | 42/9 |
| Trimethoprim-sulfamethoxazole | 12 | 24/5 | 0 | 0 | 37 | 75/5 |
| Gentamicin | 34 | 69/4 | 0 | 0 | 15 | 30/6 |
| Imipenem | 49 | 100 | 0 | 0 | 0 | 0 |
| Nitrofurantoin | 47 | 95/9 | 0 | 0 | 2 | 4/1 |
| Ofloxacin | 28 | 57/1 | 0 | 0 | 21 | 42/9 |
| Piperacillin | 4 | 8/2 | 0 | 0 | 45 | 91/8 |
Distribution of virulence genes in pulsotypes.
| Virulence factors | Pap | afa | sfa | Total isolates in pulsotypes | |||
|---|---|---|---|---|---|---|---|
| Pulsotypes | Number | % | Number | % | Number | % | |
| A | 3 | 18.75 | 4 | 25 | 1 | 6.25 |
|
| B | 1 | 12.5 | 1 | 12.5 | 2 | 25 |
|
| C | 1 | 20 | 1 | 20 | 2 | 40 |
|
| D | 1 | 25 | 1 | 25 | 1 | 25 |
|
| E | 1 | 25 | 0 | 0 | 1 | 25 |
|
| F | 0 | 0 | 0 | 0 | 0 | 0 |
|
| G | 0 | 0 | 1 | 33.33 | 0 | 0 |
|
| H | 1 | 33.33 | 0 | 0 | 0 | 0 |
|
| I | 1 | 50 | 1 | 50 | 1 | 50 |
|
| J | 0 | 0 | 0 | 0 | 1 | 100 |
|
|
| |||||||
| Total isolates | 9 | 18.36 | 9 | 18.36 | 9 | 18.36 | 49 |
Distribution of virulence phenotyping in pulsotypes.
| Virulence phenotyping | Haemolysin | Hydrophobicity | Haemagglutination | Total isolates in pulsotypes | |||
|---|---|---|---|---|---|---|---|
| Pulsotypes | Number | % | Number | % | Number |
| |
| A | 3 | 18.7 | 3 | 18.7 | 7 | 43.7 |
|
| B | 3 | 37.5 | 0 | 0 | 3 | 37.5 |
|
| C | 2 | 40 | 2 | 40 | 3 | 60 |
|
| D | 0 | 0 | 0 | 0 | 1 | 25 |
|
| E | 0 | 0 | 0 | 0 | 3 | 75 |
|
| F | 0 | 0 | 1 | 33.3 | 2 | 66.6 |
|
| G | 0 | 0 | 0 | 0 | 2 | 66.6 |
|
| H | 0 | 0 | 0 | 0 | 2 | 66.6 |
|
| I | 1 | 50 | 1 | 50 | 1 | 50 |
|
| J | 0 | 0 | 0 | 0 | 1 | 100 |
|
|
| |||||||
| Total isolates | 9 | 18.36 | 7 | 14.28 | 25 | 51.02 | 49 |